Working… Menu

Anti-VEGF Treatment for Prevention of PDR/DME

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02634333
Recruitment Status : Active, not recruiting
First Posted : December 18, 2015
Last Update Posted : July 23, 2020
Regeneron Pharmaceuticals
Juvenile Diabetes Research Foundation
National Eye Institute (NEI)
National Institutes of Health (NIH)
Information provided by (Responsible Party):
Jaeb Center for Health Research

No Study Results Posted on for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : May 2020
Estimated Study Completion Date : May 2022
Submission Cycle Results Submitted to Results Returned after Quality Control Review
1 June 21, 2021